Pembrolizumab News
Latest articles and news about Pembrolizumab on AXL Media.
Latest Articles
- Non-Invasive Liquid Biopsy Breakthrough Predicts Immunotherapy Success in High-Risk Breast Cancer Patients
Published: May 1, 2026
Section: Medical News
A study led by Vanderbilt-Ingram Cancer Center researchers reveals that repeated blood sampling can predict how patients with early-stage breast cancer will respond to immunotherap...
- UCL NEOPRISM-CRC Trial Reports Zero Relapses for Bowel Cancer Patients Using Pre-Op Immunotherapy
Published: Apr 21, 2026
Section: Medical News
Long-term results from the NEOPRISM-CRC clinical trial show that a short course of pembrolizumab immunotherapy before surgery has kept 100% of high-risk bowel cancer patients cance...
- Zero Relapse Rate Reported in UCL Trial Using Pre-Operative Immunotherapy for High-Risk Bowel Cancer
Published: Apr 21, 2026
Section: Medical News
The NEOPRISM-CRC clinical trial, led by University College London (UCL) and UCLH, has demonstrated a remarkable 100% cancer-free rate after three years for patients with specific h...
- University of Cincinnati Cancer Center Identifies Overlooked Genetic Mutations and Fat Tissue Biomarkers to Refine Precision Oncology
Published: Apr 18, 2026
Section: Health Technology
Researchers at the University of Cincinnati will present three major abstracts at the AACR 2026 meeting, highlighting how "silent" genetic mutations and peritumoral fat tissue infl...
- Phase 3 LITESPARK 022 study establishes new oral combination therapy for preventing kidney cancer recurrence after surgery
Published: Mar 2, 2026
Section: Health Technology
A global clinical trial has demonstrated that combining the HIF 2α inhibitor belzutifan with standard immunotherapy significantly reduces the risk of relapse in patients with clear...
- Phase 3 trial shows belzutifan and pembrolizumab combination reduces kidney cancer recurrence risk after surgery
Published: Mar 2, 2026
Section: Health
Patients with clear cell renal cell carcinoma at high risk of relapse demonstrated improved disease free survival when treated with a combination of belzutifan and pembrolizumab. D...
- Laser Heat Therapy Combined with Immunotherapy Shatters Survival Records for Deadly Brain Cancer
Published: Feb 26, 2026
Section: Medical News
A breakthrough Phase 1/2b clinical trial from Keck Medicine of USC has found that combining Laser Interstitial Thermal Therapy (LITT) with the immunotherapy drug pembrolizumab can...